Repligen | RGEN - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Agilent USD 615M 13M 2026-03
Align Technology USD 109.84M 13.88M 2026-06
Bio Techne USD 95.6M 3.97M 2026-03
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Bruker USD 200.2M 68.9M 2026-06
Charles River Laboratories USD 140.98M 7.03M 2026-06
Danaher USD 2.07B 282M 2026-06
Dentsply International USD 260M 1000K 2026-06
General Electric Aerospace USD 10.82B 139M 2026-06
Henry Schein USD 1.14B 92M 2026-06
Illumina USD 230M 12M 2026-06
IQVIA Holdings USD 3.61B 31M 2026-06
Mettler Toledo International USD 229.8M 1.08M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
OraSure Technologies USD 8.4M 2.23M 2026-06
Pacific Biosciences Of California USD 19.22M 5.61M 2026-06
Pfizer USD 4.58B 75M 2026-06
Repligen USD 33.23M 1.42M 2026-06
Revvity USD 165.74M 3.94M 2026-06
Standard Biotools USD 8.01M 2.6M 2026-03
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Waters USD 602M 498.22M 2026-03
West Pharmaceutical Services USD 252.7M 400K 2026-06